New ointment shows promise for severe Fish-Scale skin disease

NCT ID NCT05295732

Completed Disease control Sponsor: LEO Pharma Source: ClinicalTrials.gov ↗

First seen Nov 17, 2025 · Last updated May 23, 2026 · Updated 22 times

Summary

This study tested an ointment called TMB-001 in 153 people aged 6 and older with a rare, inherited skin condition that causes thick, scaly skin (ichthyosis). Participants applied the ointment daily for 12 weeks, and doctors measured improvements in scaling and cracking. The goal was to see if the treatment could safely control the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

About Skin Dermatology

Centennial, Colorado, 80111, United States
Ambulatorio di Malattie Rare Dermatologiche e Immunopatologia Cutanea

Florence, 50125, Italy
Ann & Robert H. Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States
Associated Skincare Specialists

New Brighton, Minnesota, 55112, United States
Austin Institute for Clinical Research

Houston, Texas, 77056, United States
Austin Institute for Clinical Research, Inc.

Pflugerville, Texas, 78660, United States
CHU de Nantes Hotel Dieu

Nantes, 44093, France
Charité - Universitätsmedizin Berlin

Berlin, 10117, Germany
Children's Hospital of Philadelphia (CHOP)

Philadelphia, Pennsylvania, 19104, United States
Dawes Fretzin Clinical Research Group, LLC

Indianapolis, Indiana, 46250, United States
Department of Dermatology and Cutaneous Surgery, University of Miami

Miami, Florida, 33136, United States
Dr. Chih-ho Hong Medical Inc.

Surrey, British Columbia, V3R 6A7, Canada
Fondazione IRCCS Ospedale Maggiore Policlinico Milano, Area Materno Infantile - SC pediatria Pneumoinfettivologia

Milan, Italy
Hopital Larrey CHU Toulouse

Toulouse, 31059, France
Hopital Necker APHP

Paris, 75015, France
Hôpital Femme Mère Enfant

Bron, 69677, France
Katholisches Kinderkrankenhaus Wilhelmstift GmbH

Hamburg, 22149, Germany
Medical University of South Carolina

Charleston, South Carolina, 29425, United States
Münster University Hospital

Münster, 48149, Germany
North Sound Dermatology

Mill Creek, Washington, 98012, United States
Optima Research

Boardman, Ohio, 44512, United States
SickKids Hospital

Toronto, Ontario, M5G 1X8, Canada
Stanford University School of Medicine

Palo Alto, California, 94304, United States
Stollery Children's Hospital

Edmonton, Alberta, T6G 2B7, Canada
The Indiana Clinical Trials Center

Plainfield, Indiana, 46168, United States
U.O. di Dermatologia Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale

Bologna, 40138, Italy
U.O. di Dermatologia e Venereologia Universitaria

Bari, 70124, Italy
U.O.C. di Dermatologia Dipartimento Pediatrico Universitario Ospedaliero

Roma, 00165, Italy
U.S. Dermatology Partners

Phoenix, Arizona, 85006, United States
University of Mississippi Medical Center (UMMC)

Jackson, Mississippi, 39216, United States
Universitätsklinikum Erlangen

Erlangen, 91054, Germany
Virginia Clinical Research-Pariser Dermatology Specialists

Norfolk, Virginia, 23502, United States
Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27104, United States
Wiseman Dermatology Research Inc.

Winnipeg, Manitoba, R3M 3Z4, Canada
Yale Center for Clinical Investigation

New Haven, Connecticut, 06519, United States

Conditions

Explore the condition pages connected to this study.

ICHTHYOSIS